Malignant thymoma is a rare cancer that develops in the thymus gland, a small organ behind the breastbone that helps the immune system develop properly. Though uncommon, this disease presents unique challenges for patients and doctors alike, particularly because it can remain silent in early stages and is often linked to unusual immune system disorders.

Understanding Malignant Thymoma

Malignant thymoma, also called thymic epithelial tumor, starts in the cells that cover the outer surface of the thymus gland. This small organ sits in the upper chest, tucked between the lungs and above the heart. The thymus plays a crucial role in developing white blood cells called T-lymphocytes or T-cells, which protect the body from infections. After puberty, the thymus gradually shrinks and is replaced by fatty tissue, which is why these cancers typically affect adults rather than children.^[1]

The term “malignant thymoma” can be somewhat confusing because medical experts now consider all thymomas to have the potential to be cancerous, even if they grow slowly. What distinguishes different types is how aggressively they behave. Standard thymomas grow slowly and rarely spread beyond the thymus itself. In contrast, thymic carcinoma develops much more rapidly and is far more likely to spread to other parts of the body, such as the lungs, bones, or liver. About one in every five thymic epithelial tumors is a thymic carcinoma, and these are considerably harder to treat than slower-growing thymomas.^[2]

The thymus consists of two main cell types that can both transform into cancer. When epithelial cells grow abnormally, they lead to thymoma or thymic carcinoma. When lymphocytes grow abnormally instead, they cause different cancers called Hodgkin or non-Hodgkin lymphoma, which are not considered thymic epithelial tumors even though they originate in the same organ.^[1]

How Common Is Malignant Thymoma

Malignant thymoma is genuinely rare. Despite being the most common tumor found in the front part of the chest in adults, thymic epithelial tumors represent only about 0.2% to 1.5% of all cancers. They account for approximately 20% of all masses found in the area of the chest called the mediastinum. Only about 400 people in the United States receive this diagnosis each year, making it an uncommon condition even among rare cancers.^[1][3]

The disease most commonly affects adults between the ages of 40 and 75, with the peak occurring between the fourth and sixth decades of life. Some sources indicate that most patients are in their 70s when diagnosed. Interestingly, malignant thymoma does not show a preference for one gender over another, and no clear racial predilection exists overall. However, in the United States specifically, most people diagnosed with thymoma have Asian or Pacific Islander heritage.^[1][3]

For patients with thymic carcinoma or those whose thymoma has spread widely, the outlook is more challenging. The five-year survival rate drops to 36% for patients with locally advanced, inoperable carcinoma and 24% for those with metastatic disease. Long-term survival depends heavily on whether the tumor can be completely removed through surgery.^[15]

What Causes Malignant Thymoma

The exact cause of malignant thymoma remains unknown. Unlike many other cancers, no specific risk factors have been identified that increase a person’s chance of developing this disease. Researchers have not found links to lifestyle choices, environmental exposures, genetic mutations passed down through families, or any other clear triggers. This lack of known causes makes prevention strategies difficult to develop.^[3]

What scientists do understand is that malignant thymoma involves abnormal growth of the epithelial cells in the thymus. These cells begin dividing uncontrollably, forming a mass that can range in size from microscopic to over 30 centimeters. In gross examination, thymomas typically appear as well-defined, tan, firm masses. The tumor can develop not only in the thymus itself but occasionally in unusual locations such as the neck, the area where the lungs connect to the airways, the thyroid gland, the lung tissue, the membrane covering the lungs, or the sac surrounding the heart.^[3]

Malignant thymomas show considerable variation in their microscopic appearance, with many displaying histologic heterogeneity, meaning different areas of the same tumor can look quite different under the microscope. This variation makes it challenging to distinguish between less aggressive and more aggressive forms based solely on how the cells appear, though more invasive thymomas do show distinct patterns of spreading into surrounding tissues.^[3]

Risk Factors

As mentioned, there are no established risk factors for developing malignant thymoma. Age is the only demographic factor consistently associated with the disease, as it predominantly affects middle-aged and older adults. The disease can occur in younger people but is uncommon in children and adolescents.^[3]

Rather than having risk factors that lead to thymoma, patients with this disease often develop associated conditions as a result of the tumor. Between 30% and 65% of people with thymoma experience an autoimmune condition called myasthenia gravis, which causes muscle weakness because the body’s immune system mistakenly attacks the connections between nerves and muscles. An additional 5% of patients develop other paraneoplastic syndromes, which are conditions that occur when the immune system attacks not only cancer cells but also healthy tissues throughout the body.^[2][3]

Recognizing the Symptoms

Many people with malignant thymoma have no symptoms when first diagnosed. The tumor is often discovered accidentally when a chest X-ray or CT scan is performed for another reason entirely. When symptoms do appear, they typically arise because the growing tumor presses on nearby organs or structures in the chest, or because of associated autoimmune conditions.^[2]

The most common symptoms related to the tumor itself include chest pain or a feeling of pressure on the chest, a persistent cough that will not go away, shortness of breath, and difficulty swallowing. These symptoms develop as the tumor grows large enough to compress or push against the windpipe, esophagus, or other chest structures.^[1][2]

A particularly serious complication occurs when the tumor blocks or squeezes the large veins that carry blood from the upper body back to the heart. These veins are called the vena cava, and compression can cause superior vena cava syndrome. This condition creates noticeable swelling in the face, neck, and upper chest, sometimes with a bluish color to the skin. Visible veins may bulge in the upper body. Patients may also experience persistent coughing, difficulty breathing, extreme fatigue, dizziness, and headaches. This syndrome requires urgent medical attention.^[1][4]

Symptoms related to autoimmune paraneoplastic syndromes vary depending on which condition develops. Myasthenia gravis causes progressive muscle weakness, typically starting with drooping eyelids, double vision, difficulty swallowing or speaking, and weakness in the arms and legs. Pure red cell aplasia prevents the bone marrow from making enough red blood cells, leading to anemia with symptoms of extreme fatigue, pale skin, shortness of breath, and dizziness. Hypogammaglobulinemia, also called Good syndrome, weakens the immune system’s ability to produce antibodies, making patients vulnerable to repeated infections.^[1][2]

Less common autoimmune conditions associated with thymoma include polymyositis (inflammation causing muscle pain and weakness), lupus erythematosus (a systemic disease affecting multiple organs), rheumatoid arthritis (joint inflammation), thyroiditis (thyroid gland inflammation), and Sjögren syndrome (affecting moisture-producing glands). These conditions can develop before, during, or after the thymoma diagnosis.^[1]

Prevention Strategies

Because no risk factors have been identified for malignant thymoma, there are no specific prevention strategies that can reduce the chance of developing this disease. Unlike cancers linked to smoking, diet, sun exposure, or inherited genetic mutations, thymoma appears to develop without clear external triggers. This means lifestyle modifications, dietary changes, or screening programs have not been shown to prevent thymic epithelial tumors.^[3]

For individuals already diagnosed with thymoma, particularly those who have completed treatment, long-term follow-up care becomes a form of secondary prevention. Thymomas have an unusual characteristic: they can recur many years after seemingly successful treatment, even up to 20 years later. Because of this extended risk period, lifetime follow-up with regular doctor visits and imaging studies is recommended for people treated for thymoma. These appointments serve as surveillance, aiming to detect any recurrence as early as possible when it is most treatable.^[17][19]

Patients who have been treated for thymoma also face a higher risk of developing second cancers later in life. The second cancers most commonly reported include non-Hodgkin lymphoma and soft tissue sarcoma. This increased risk appears regardless of whether patients were treated with surgery alone or received radiation therapy, and it may also be higher in those who had myasthenia gravis. While this elevated risk cannot be prevented, awareness of it helps doctors and patients stay vigilant for symptoms of new cancers during follow-up care.^[19]

How Malignant Thymoma Affects the Body

Understanding the pathophysiology of malignant thymoma—how the disease changes normal body functions—requires looking at both the physical effects of the tumor and its impact on the immune system. The thymus gland reaches its maximum size and function around puberty, then gradually shrinks throughout adult life. When malignant thymoma develops, abnormal epithelial cells begin multiplying, creating a mass that disrupts this normal pattern.^[1]

Physically, as the tumor grows within the confined space of the chest, it can compress vital structures. The tumor typically forms in the area called the anterior mediastinum, directly behind the breastbone and in front of the heart. From this location, an expanding mass can press against the trachea (windpipe), making breathing difficult. It can squeeze the esophagus, causing problems with swallowing. In severe cases, it can compress the superior vena cava, the large vein that returns blood from the head, neck, and arms to the heart, creating the dangerous superior vena cava syndrome described earlier.^[3]

The most distinctive pathophysiological feature of thymoma involves its disruption of normal immune system development. The thymus is where immature T-cells undergo “education” to distinguish between the body’s own cells and foreign invaders. In a healthy thymus, cells that would attack the body’s own tissues are eliminated through a process called negative selection. The gene responsible for this quality control is called AIRE, the autoimmune regulator gene.^[15]

In thymomas, decreased expression of the AIRE gene means that autoreactive T-cells—cells programmed to attack the body’s own tissues—are not properly eliminated. Instead, they mature and are released into the bloodstream. Additionally, the tumor causes abnormalities in circulating T-cell populations, including unusual activation patterns. These defective T-cells then target various tissues throughout the body, creating the autoimmune conditions so commonly seen with thymoma.^[15]

Beyond T-cell abnormalities, patients with thymoma can develop problems with B-cells, another type of immune cell that produces antibodies. Some patients develop B-cell lymphopenia (too few B-cells) and produce antibodies against their own immune system proteins called cytokines. This combination creates an immune deficiency state, paradoxically making patients vulnerable to opportunistic infections even as other parts of their immune system are overactive and attacking healthy tissues.^[15]

When thymoma spreads beyond the thymus—which standard thymomas rarely do—it most commonly extends to the membrane covering the lungs, called the pleura. Thymic carcinoma, being more aggressive, is more likely to spread to distant organs including the bones, liver, and other sites throughout the body. This spread, called metastasis, occurs when cancer cells break away from the original tumor and travel through the bloodstream or lymphatic system to establish new tumors elsewhere.^[2][8]

The biological behavior of thymic epithelial tumors is related to their microscopic appearance, classified by the World Health Organization system. Type A thymomas usually grow slowly, while Type B thymomas can grow more quickly. Thymic carcinomas, which look very different from normal thymus tissue under the microscope, behave most aggressively. Interestingly, thymic epithelial tumors have the lowest tumor mutational burden of all solid tumors in adults, meaning they have fewer genetic mutations than most other cancers. This characteristic has implications for treatment, as many newer cancer therapies target specific mutations.^[15]